About Molecular Dimensions
Molecular Dimensions is a company based in Newmarket (United Kingdom) founded in 1998 was acquired by Anatrace in February 2017. Molecular Dimensions operates in a competitive market with competitors including Bio Rad, Thermo Fisher Scientific, Siemens Healthineers, Merck and Quanterix, among others.
- Headquarter Newmarket, United Kingdom
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website moleculardimensions.com/en
- Social LinkedIn X Facebook
- Acquired by Anatrace (Feb 2017)
- Legal Name Molecular Dimensions Ltd
- Date of Incorporation 22 Feb, 1984
- Jurisdiction ROTHERHAM, UNITED KINGDOM
Investors in Molecular Dimensions
Molecular Dimensions has secured backing from 1 investor. Prominent investors backing the company include Anatrace.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Supplies detergents, lipids, and related products for life science research. | 1985 | anatrace.com | Maumee, United States |
Investor details for Molecular Dimensions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Molecular Dimensions
2 dated milestones of Molecular Dimensions across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Molecular Dimensions is founded.
- Exit Acquired by Anatrace.
Competitors of Molecular Dimensions
Molecular Dimensions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Thermo Fisher Scientific, Siemens Healthineers, Merck and Quanterix, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bio-rad.com | 1952 | Hercules, United States | – | 10 | Portfolio of products and services for life science research and clinical diagnostic markets | |
| thermofisher.com | 1956 | Waltham, United States | – | 75,000 | Electron microscopy services and microanalysis instruments are provided. | |
| siemens-healthineers.com | 1847 | Erlangen, Germany | – | 66,000 | AI-based medical diagnostics are developed for healthcare applications. | |
| merckgroup.com | 1668 | Darmstadt, Germany | – | 922 | Merck is engaged in science and technology solutions globally. | |
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. | |
| biolifesolutions.com | 1987 | Bothell, United States | – | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | |
| apbiocode.com | 2008 | Santa Fe Springs, United States | $20.29M | 66 | Assay kits and instruments for in vitro diagnostics are developed. |
Detailed competitors of Molecular Dimensions
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Molecular Dimensions
The website of Molecular Dimensions (moleculardimensions.com) receives about 11.7K visits a month.
- Monthly visits11.7K
▲ 12.2% vs previous month
Websites whose visitors overlap most with Molecular Dimensions. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| rigakureagents.com | 100% | – | #5,395,694 | View details | |
hamptonresearch.com | hamptonresearch.com | 92% | – | #1,884,073 | – |
| mitegen.com | 91% | 16.9K | #1,460,573 | View details | |
| polysciences.com | 83% | 41.7K | #718,870 | View details | |
| ttplabtech.com | 79% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Molecular Dimensions
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Molecular Dimensions
Complete news archive for Molecular Dimensions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Molecular Dimensions
10 companies that operate in the same segment as Molecular Dimensions (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Molecular Dimensions
Molecular Dimensions was founded in 1998.
Molecular Dimensions is headquartered in Newmarket, United Kingdom. It is registered at Newmarket, England, United Kingdom.
Molecular Dimensions was established in 1998 in Newmarket, United Kingdom, within the biotechnology sector focused on X-ray crystallography tools. Reagents, screens, consumables, and instrumentation for protein structure determination are produced and distributed. The portfolio encompasses stability screens, crystallization kits, optimization tools, protein production aids, and cryocrystallography systems, supporting research operations globally.
Molecular Dimensions's top competitors include Thermo Fisher Scientific, Biocare Medical and Merck.
Molecular Dimensions has 1 investor. Key investors include Anatrace.
Molecular Dimensions operates through Molecular Dimensions Ltd.
Yes. Molecular Dimensions was acquired by Anatrace in February 2017.